中山醫學大學機構典藏 CSMUIR:Items for Author

Year

Loading year class tree, please wait....

Collection	Date	Title	Authors
[中山醫學大學研究成果] 其他文獻	2021	SAFETY OF BELIMUMAB IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: YEAR 2 FOLLOW-UP OF A LARGE PHASE 4, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY	Sheikh, S; Scheinberg, M; Wei, JCC; Tegzova, D; Stohl, W; Mucenic, T; Punwaney, R; Kurrasch, R; Harris, J; Muzaffar, S; Fernandes, S; Fox, NL; Liu, A; Quasny, H; Roth, D
[中山醫學大學研究成果] 其他文獻	2021	Year-3 Observational Follow-up of Belimumab Safety (Mortality and Malignancies) in Patients with SLE Who Completed a Phase 4, 52-Week, Randomized, Double-Blind Placebo-Controlled Safety Study	Sheikh, S; Wei, CC; Tegzova, D; Stohl, W; de Toledo, RA; Mucenic, T; Banfi, MA; Maksimowicz-McKinnon, K; Abud-Mendoza, C; Navarra, S; Garcia, M; Garcia-De La Torre, I; Kurrasch, R; Fernandes, S; Harris, J; Muzaffar, S; Fox, NL; Liu, A; Quasny, H; Roth, D
[中山醫學大學研究成果] 期刊論文	2021	Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial	Sheikh, SZ; Scheinberg, MA; Wei, JCC; Tegzova, D; Stohl, W; de Toledo, RA; Mucenic, T; Banfi, MRA; Maksimowicz-McKinnon, K; Abud-Mendoza, C; Navarra, S; Garcia, M; Garcia-De La Torre, I; Ros, JO; Levy, RA; Bass, DL; Terres, JR; Punwaney, R; Harris, J; Nami, A; Pierce, A; Thorneloe, KS; Ji, B; Roth, DA